Combined therapy with rosuvastatin and ezetimibe on inflammatory state and pro-inflammatory cytokines in patients with coronary heart disease and metabolic syndrome
25 May 2019 (08:30 - 17:30)
Organised by:
Abstract
About the speaker
Republican Specialized Scientific-Practical Medical Center Therapy and Medical Rehabilitation, Tashkent (Uzbekistan)
11 More presentations in this session
Access the full session
The Event
Heart Failure 2019
25 May 2019
08:30 CET
